311 related articles for article (PubMed ID: 25046810)
21. Long-term vaginal ring pessary use: discontinuation rates and adverse events.
Sarma S; Ying T; Moore KH
BJOG; 2009 Dec; 116(13):1715-21. PubMed ID: 19906018
[TBL] [Abstract][Full Text] [Related]
22. The impact of pessary use on bowel symptoms: one-year outcomes.
Brazell HD; Patel M; O'Sullivan DM; Mellen C; LaSala CA
Female Pelvic Med Reconstr Surg; 2014; 20(2):95-8. PubMed ID: 24566213
[TBL] [Abstract][Full Text] [Related]
23. Vaginal Pessary for Pelvic Organ Prolapse: A French Multidisciplinary Survey.
Pizzoferrato AC; Nyangoh-Timoh K; Martin-Lasnel M; Fauvet R; de Tayrac R; Villot A
J Womens Health (Larchmt); 2022 Jun; 31(6):870-877. PubMed ID: 34569823
[No Abstract] [Full Text] [Related]
24. Discontinuation rate and adverse events after 1 year of vaginal pessary use in women with pelvic organ prolapse.
Yimphong T; Temtanakitpaisan T; Buppasiri P; Chongsomchai C; Kanchaiyaphum S
Int Urogynecol J; 2018 Aug; 29(8):1123-1128. PubMed ID: 28815277
[TBL] [Abstract][Full Text] [Related]
25. Patient satisfaction and changes in prolapse and urinary symptoms in women who were fitted successfully with a pessary for pelvic organ prolapse.
Clemons JL; Aguilar VC; Tillinghast TA; Jackson ND; Myers DL
Am J Obstet Gynecol; 2004 Apr; 190(4):1025-9. PubMed ID: 15118635
[TBL] [Abstract][Full Text] [Related]
26. Effect of pessary use on genital hiatus measurements in women with pelvic organ prolapse.
Jones K; Yang L; Lowder JL; Meyn L; Ellison R; Zyczynski HM; Moalli P; Lee T
Obstet Gynecol; 2008 Sep; 112(3):630-6. PubMed ID: 18757662
[TBL] [Abstract][Full Text] [Related]
27. Pessaries for pelvic organ prolapse: evaluation of vaginal discharge and pain during pessary cleaning in an outpatient setting.
Kruyt LM; van der Ploeg JM; Lammers K; van Etten-Debruijn BA; Niemeijer AS; Hakvoort RA
Int Urogynecol J; 2024 Feb; 35(2):333-339. PubMed ID: 37796331
[TBL] [Abstract][Full Text] [Related]
28. Location and motion of vaginal pessaries in situ in women with successful and unsuccessful pessary treatment for pelvic organ prolapse.
Boogaard LL; Triepels CPR; Verhamme LM; van Kuijk SMJ; Donners JJAE; Kluivers KB; Maal TJJ; Weemhoff M; Notten KJB
Int Urogynecol J; 2023 Sep; 34(9):2293-2300. PubMed ID: 37119269
[TBL] [Abstract][Full Text] [Related]
29. Is hysterectomy or prior reconstructive surgery associated with unsuccessful initial trial of pessary fitting in women with symptomatic pelvic organ prolapse?
Nemeth Z; Farkas N; Farkas B
Int Urogynecol J; 2017 May; 28(5):757-761. PubMed ID: 27796427
[TBL] [Abstract][Full Text] [Related]
30. The Impact of Vaginal Probiotics on Pessary Use: A Randomized Controlled Trial.
Sappenfield EC; Mellen C; Wilcox J; O'Hanlon DE; O'Sullivan DM; Tunitsky-Bitton E
Urogynecology (Phila); 2024 Jan; 30(1):50-58. PubMed ID: 37493229
[TBL] [Abstract][Full Text] [Related]
31. Management of incarcerated vaginal pessaries.
Poma PA
J Am Geriatr Soc; 1981 Jul; 29(7):325-7. PubMed ID: 7240622
[TBL] [Abstract][Full Text] [Related]
32. Effect of Local Estrogen Cream on Vaginal Health after Pessary Use for Prolapsed Pelvic Organ: A Randomized Controlled Trial.
Tontivuthikul P; Sanmee U; Wongtra-Ngan S; Pongnarisorn C
J Med Assoc Thai; 2016 Jul; 99(7):757-63. PubMed ID: 29901374
[TBL] [Abstract][Full Text] [Related]
33. Which factors should be considered in choosing pessary type and size for pelvic organ prolapse patients in a fitting trial?
Ding J; Song XC; Deng M; Zhu L
Int Urogynecol J; 2016 Dec; 27(12):1867-1871. PubMed ID: 27260324
[TBL] [Abstract][Full Text] [Related]
34. Are older patients with prolapse likely to continue pessary use? A retrospective observational study.
Dykes N; Lim YN; Zilberlicht A; Dwyer PL
Int Urogynecol J; 2023 Dec; 34(12):2919-2923. PubMed ID: 37572122
[TBL] [Abstract][Full Text] [Related]
35. Changes of intravaginal microbiota and inflammation after self-replacement ring pessary therapy compared to continuous ring pessary usage for pelvic organ prolapse.
Yoshimura K; Morotomi N; Fukuda K; Kubo T; Taniguchi H
J Obstet Gynaecol Res; 2020 Jun; 46(6):931-938. PubMed ID: 32189434
[TBL] [Abstract][Full Text] [Related]
36. Vaginal evisceration during pessary fitting and treatment with immediate colpocleisis.
Rubin R; Jones KA; Harmanli OH
Obstet Gynecol; 2010 Aug; 116 Suppl 2():496-498. PubMed ID: 20664431
[TBL] [Abstract][Full Text] [Related]
37. Feasibility of using pessaries for treatment of pelvic organ prolapse in rural Nepal.
Robert M; Govan AJ; Lohani U; Uprety A
Int J Gynaecol Obstet; 2017 Mar; 136(3):325-330. PubMed ID: 28099682
[TBL] [Abstract][Full Text] [Related]
38. Quality of life and vaginal symptoms of postmenopausal women using pessary for pelvic organ prolapse: a prospective study.
Coelho SCA; Marangoni-Junior M; Brito LGO; Castro EB; Juliato CRT
Rev Assoc Med Bras (1992); 2018 Dec; 64(12):1103-1107. PubMed ID: 30569986
[TBL] [Abstract][Full Text] [Related]
39. Host inflammatory response in women with vaginal epithelial abnormalities after pessary use.
Ramaseshan AS; Mellen C; O'Sullivan DM; Nold C; Tulikangas PK
Int Urogynecol J; 2022 Aug; 33(8):2151-2157. PubMed ID: 34748034
[TBL] [Abstract][Full Text] [Related]
40. Optimal Pessary Care: A Modified Delphi Consensus Study.
Hooper GL; Atnip S; O'Dell K
J Midwifery Womens Health; 2017 Jul; 62(4):452-462. PubMed ID: 28727233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
